Db Wealth Management Group, LLC Gilead Sciences, Inc. Transaction History
Db Wealth Management Group, LLC
- $169 Million
- Q4 2023
A detailed history of Db Wealth Management Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Db Wealth Management Group, LLC holds 39 shares of GILD stock, worth $3,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$3,435
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...